A new non-surgical treatment for low-risk prostate cancer effectively
kills cancer cells while preserving healthy tissue, reports a new phase
III clinical trial in 413 patients led byÌýProfessor
Mark Emberton,
Dean of UCL Medical Sciences. ,Ìý, , , , ,Ìý, , , ,Ìý
»Ê¼Ò»ªÈËews, ,Ìý,